Last reviewed · How we verify

Iodine (Betadine)

University of California, Los Angeles · Phase 3 active Small molecule

Iodine (Betadine) is a broad-spectrum antimicrobial agent that kills microorganisms by oxidizing and disrupting their cellular proteins and nucleic acids.

Iodine (Betadine) is a broad-spectrum antimicrobial agent that kills microorganisms by oxidizing and disrupting their cellular proteins and nucleic acids. Used for Topical antisepsis and disinfection of skin wounds, Surgical site preparation, Prevention of infection in minor cuts and abrasions.

At a glance

Generic nameIodine (Betadine)
SponsorUniversity of California, Los Angeles
Drug classTopical antiseptic/disinfectant
ModalitySmall molecule
Therapeutic areaInfectious Disease / Dermatology
PhasePhase 3

Mechanism of action

Betadine is a povidone-iodine complex that releases iodine, which acts as a potent oxidizing agent. It denatures proteins and disrupts the cell membranes and DNA/RNA of bacteria, viruses, fungi, and other pathogens, making it effective as a topical antiseptic and disinfectant. The mechanism is non-selective and rapid, making it useful for wound preparation and infection prevention.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: